Europe’s Hidden Campylobacter coli Lineage Moves Across Borders and Sectors
A multidrug-resistant Campylobacter coli lineage has been circulating across Europe for years without recognition as a single connected problem. Whole-genome sequencing of 217 isolates from nine countries now links human, animal, food, and environmental sources to the same sequence type, ST10042, with cross-border clustering centered largely in Portugal and Luxembourg.
The finding is clinically important because Campylobacteriosis is already the leading bacterial foodborne gastroenteritis in Western countries, and treatment options narrow quickly when resistance accumulates across several drug classes at once. In this lineage, the resistance profile was conserved: fluoroquinolones, tetracyclines, and β-lactams were all affected, and reduced susceptibility to carbapenems also appeared in the dataset.
That pattern is not random noise in scattered isolates. It points to sustained clonal expansion, with increasing diversification over time, rather than isolated spillover events detected one country at a time.
A Multisectoral Signal Emerging From Routine Surveillance
Portugal provided the surveillance backbone for the investigation. Since 2013, the national reference laboratory has coordinated sentinel laboratory-based monitoring of human campylobacteriosis across major population centers and private laboratory networks, while animal and food-chain surveillance has contributed isolates from cattle, broiler, and turkey cecal contents at slaughter, plus additional material from retail poultry meat, dogs, and environmental sampling.
From that framework, investigators assembled a retrospective and prospective dataset that captured ST10042 across years and sectors. Since whole-genome sequencing was systematically implemented in Portugal in 2022, coverage has reached about 90% for C. coli isolates with antimicrobial susceptibility testing, making it possible to see a lineage that had previously been underrecognized in public databases.
The broader European picture sharpened when collaborators from Germany, Luxembourg, France, Ireland, Denmark, and the Netherlands added isolates generated through national sequencing programs or research monitoring, with a limited number from the United Kingdom and Spain retrieved from PubMLST. In total, 217 isolates were integrated into the analysis.
Why the Resistance Pattern Matters at the Bedside
Campylobacteriosis usually presents with bloody or watery diarrhea, abdominal cramping, fever, vomiting, and nausea. Most cases are self-limited, but severe or prolonged infection can lead to bacteremia, hospitalization, or death, especially in young children, older adults, and immunocompromised patients. When antimicrobial treatment becomes necessary, resistance to fluoroquinolones and macrolides has long complicated care; the emergence of broader resistance, including reduced carbapenem susceptibility, raises the stakes further.
In ST10042, the resistance profile was tied to specific genomic features. GyrA Thr86Ile was associated with fluoroquinolone resistance, tet(O/32/O) and tet(O) genes tracked with tetracycline resistance, and promoter variants in bla OXA-61 were linked to β-lactam resistance. Variation in porA, the major outer-membrane porin, was associated with variable susceptibility to amoxicillin/clavulanic acid and ertapenem, consistent with altered membrane permeability limiting antibiotic influx.
The biology is straightforward and unsettling: a lineage can preserve broad transmissibility while quietly accumulating mechanisms that blunt several common drug classes at once. Once that happens, the usual assumption that a case is a one-off gastrointestinal infection becomes less reliable.
A Clonal Lineage With International Reach
Comparative genomic analysis showed that the ST10042 population did not behave like a loose collection of unrelated strains. Instead, the genomes formed cross-border clusters, including a large group linking Portugal and Luxembourg, with additional related isolates from Germany, Ireland, Spain, and the United Kingdom. The study also found ongoing diversification over time, which suggests continued circulation rather than a brief outbreak that burned out.
That international spread matters because C. coli is less often tied to outbreaks than C. jejuni, even though it has a broad ecological niche spanning broilers, pigs, wild birds, humans, food, and environmental reservoirs. A lineage that can move among those compartments can persist unnoticed unless surveillance systems actively compare genomes across sectors and countries.
A single sentence captures the clinical concern: a resistant Campylobacter lineage can travel farther than the cases it causes.
Public Health Surveillance Needs a Wider Net
The practical implication is not limited to microbiology labs. If infections caused by the same clone appear in humans, animals, food products, and environmental samples, public health responses cannot stay siloed within any one sector. Routine species-level reporting is no longer enough when a lineage can be tracked only by high-resolution genomic methods.
The study’s methods reflect that reality. Investigators combined disk-diffusion testing for ciprofloxacin, erythromycin, tetracycline, and gentamicin with MIC testing for ampicillin, amoxicillin/clavulanic acid, and ertapenem. They then used whole-genome sequencing, in silico MLST, porA typing, and resistance-gene analysis through multiple bioinformatic databases and pipelines. Comparative core-genome MLST across 1,343 loci provided the resolution needed to separate true lineage structure from background diversity.
For clinicians, the message is operational. When severe campylobacteriosis requires treatment, empiric choices are already constrained by resistance trends. A lineage with stable multidrug resistance and evidence of reduced carbapenem susceptibility narrows the margin for error even further, particularly in complicated infection or vulnerable patients.
What This Lineage Reveals About Campylobacter Ecology
The emergence of ST10042 illustrates how antimicrobial resistance can spread through a zoonotic pathogen without a single obvious source dominating the picture. Poultry remains the main reservoir for campylobacteriosis overall, but this dataset shows a lineage moving across livestock, food, humans, and environmental niches. That broader ecology helps explain why control depends on surveillance that spans the farm, the food chain, and the clinic.
It also explains why the lineage remained hidden. Public databases can underrepresent strains that do not trigger classic outbreak investigation thresholds. Sequencing changes that by revealing relatedness, transmission routes, and the accumulation of resistance determinants over time.
The study leaves a concrete warning rather than a theoretical one: C. coli ST10042 is not just a locally recurring isolate set, but a sustained international lineage with multidrug resistance and measurable genomic diversification. The remaining question is how many similar lineages are already moving across Europe before routine systems notice them.